Navigation Links
Johnson & Johnson Honors 2009 Recipient of The Dr. Paul Janssen Award for Biomedical Research
Date:9/8/2009

ean Marie Lehn, Ph.D., professor, College de France; winner, 1987 Nobel Laureate in Chemistry (France)
  • Craig Mello, Ph.D., professor, Molecular Medicine, University of Massachusetts Medical School and investigator, Howard Hughes Medical Institute; winner, 2006 Nobel Laureate in Physiology or Medicine; winner, 2006 Dr. Paul Janssen Award for Biomedical Research (United States)
  • Hartmut Michel, Ph.D., director, Department of Molecular Membrane Biology, University of Frankfurt; winner, 1988 Nobel Laureate in Chemistry (Germany)
  • Edward Scolnick, M.D., director, Psychiatry Initiative at the Broad Institute; former president, Merck Research Laboratories; member, National Academy of Sciences, the American Academy of Arts and Sciences and the Institute of Medicine (United States)
  • Sir Richard Sykes, Ph.D., chair, National Health Service, London; former rector Imperial College London; former chief executive officer, GlaxoWellcome; fellow of the Royal Society; honorary fellow of the Royal Society of Chemistry and fellow of the Academy of Medical Sciences (United Kingdom)
  • About Johnson & Johnson Pharmaceutical Services, L.L.C.

    Johnson & Johnson Pharmaceutical Services, L.L.C. is a part of the Johnson & Johnson Family of Companies. Caring for the world, one person at a time ... inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 119,400 employees at more than 250 Johnson & Johnson companies work with partners in healthcare to touch the lives of over a billion people every day, throughout the world.

        Contact:
        Seema Kumar
        Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
        908-218-6460 or '/>"/>
    SOURCE Johnson & Johnson
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology technology :

    1. Cempra Pharmaceuticals Announces Appointment of John H. Johnson to Board of Directors
    2. Johnson & Johnson Completes Acquisition of Cougar Biotechnology
    3. Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
    4. Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology
    5. Johnson & Johnson Begins Tender Offer to Acquire Cougar Biotechnology
    6. Johnson & Johnson Announces Definitive Agreement to Acquire Cougar Biotechnology, Inc.
    7. Simbionix and Johnson & Johnson LLC Announce a Distribution Agreement for Russia and the CIS Countries
    8. Burnham Announces Assay Development and License Agreement with Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
    9. Johnson & Johnson Completes Acquisition of Omrix Biopharmaceuticals, Inc.
    10. Johnson & Johnson Announces Definitive Agreement to Acquire Omrix
    11. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/11/2014)... , Not for release, publication or distribution (in ... where to do so would constitute a violation of the ... or the "Company") (LSE: SHP, NASDAQ: SHPG ) ... held a meeting with representatives of AbbVie. This ... or approval of AbbVie. A further update will ...
    (Date:7/11/2014)... 11, 2014 BCC Research ( http://www.bccresearch.com ... POLYMERASE CHAIN REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS , the ... reached nearly $140 billion in 2013. This is estimated ... five-year compound annual growth rate (CAGR) of 28.6%. , ... interesting and exciting possibilities within the broader PCR field. ...
    (Date:7/11/2014)... 2014 /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) today ... acetate) for use as a once-daily adjunctive therapy for ... who are not satisfactorily controlled with conventional therapy.  APTIOM ... under 18 years of age. Epilepsy ... according to Epilepsy Canada, it affects 0.6% of the ...
    (Date:7/11/2014)... Cayenne Medical, Inc., a privately ... soft tissue reconstruction segment, announced the worldwide launch ... involving the shoulder and extremities. The SureLock System ... deployment method. The unique delivery eliminates manual tensioning ... or anchor displacement (also commonly know as anchor ...
    Breaking Biology Technology:Shire plc - Statement re: Media Speculation 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3
    ... Emisphere Technologies, Inc.,(Nasdaq: EMIS ), a biopharmaceutical ... therapeutic molecules using its eligen(R) technology,today announced that the ... on February 12, 2008 at the Waldorf Astoria Hotel ... Chief Executive Officer of,Emisphere, will present for the company ...
    ... Feb. 4 Pfizer,s loss of some top,talent, ... gain of two,Michigan companies teaming to help speed ... metastatic bone disease, rheumatoid arthritis and,osteoporosis., Velcura ... announced,his biotechnology company will work with Dr. Sliskovic ...
    ... Number of ... Patients, MALVERN, Pa., Feb. 4 Johns Hopkins ... in the United,States to install the newest magnetic resonance ... -- the,MAGNETOM(R) Verio. Combining 3 Tesla (T) strength and ...
    Cached Biology Technology:Emisphere Technologies to Present at BIO CEO & Investor Conference on February 12 2Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease 2Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio 2Johns Hopkins Bayview at Forefront of Expanding Access to MRI With First Install of Siemens New MAGNETOM Verio 3
    (Date:7/11/2014)... from the Max Planck Institute for Medical Research in ... understanding photosynthesis, the process by which the Earth first ... and which is therefore crucial for all higher forms ... the first direct visualization of a crucial event in ... specific protein complex, photosystem II, splits water into hydrogen ...
    (Date:7/11/2014)... demonstrated that transplantation of mesenchymal stem cells can stimulate ... models of Alzheimer,s disease (AD) and improve tissue and ... studies are reported on the therapeutic effect of adipose-derived ... on the effect on oxidative injury and neurogenesis in ... her team, School of Life Sciences, Tsinghua University, China ...
    (Date:7/11/2014)... -- Research and Markets has announced the ... Industry Analysis Size Share Growth Trends and Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 The rising number ... for high level security in both private and public ... username and passwords, tokens etc. are vulnerable to attacks. ...
    Breaking Biology News(10 mins):A first direct glimpse of photosynthesis in action 2International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2
    ... has provided new insight into the consequence of ... Prion and Alzheimer,s disease. Prion and Alzheimer,s ... mutations, or more commonly, interactions between an individual,s ... neurons to become misfolded or misrouted. In these ...
    ... have bacteria in their guts that may predispose them to ... University of California, Berkeley, and the University of Arizona, Tucson. ... than a thousand people from around the world showed that ... have been linked to obesity than did people living farther ...
    ... have shifted over the past 4 to 6 years, ... rose to the fore. Scientists who are leading advisors ... examine the state-of-the-science in "Research Challenges in Climate Change: ... 14 at the American Association for the Advancement of ...
    Cached Biology News:New insight into protein misfolding in neurodegenerative disorders 2Geographic variation of human gut microbes tied to obesity 2Geographic variation of human gut microbes tied to obesity 3Hot issues in climate change research to be debated at AAAS Annual Meeting 2
    ... DMW143 taken from the SMZ line is a ... production and testing. It is available with a ... or a space-saving compact base (N2GG). This microscope ... and a projector all at the same time ...
    ... , Automatic grid, subgrid and spot finding overcome ... template assignment , ... Extensive background and signal options to optimize, ... results , Characterize more precisely ...
    This is a PYREX replacement Allihn condenser with a 34/45 inner joint on the bottom for the No. CLS3840-S 125mL extractor system. The tubulation O.D. on the condenser is 10mm....
    ... contains 400 unique human proteins on ... The proteins, a cross section of ... quadruplicate for high-quality results. Additional control ... guarantee high validity and reproducibility., ,UNIchip ...
    Biology Products: